Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial
Journal of the American Academy of Dermatology2007Vol. 58(1), pp. 106–115
Citations Over TimeTop 1% of 2007 papers
Alan Menter, Stephen K. Tyring, Kenneth B. Gordon, Alexa B. Kimball, Craig L. Leonardi, Richard G. Langley, Bruce Strober, Martin Kaul, Yihua Gu, Martin M. Okun, Kim Papp
Related Papers
- Adalimumab for Crohn's disease in New Zealand--a prospective multicentre experience.(2014)
- → The Effect of Adalimumab on Refractory Uveitis(2020)1 cited
- → FRI0165 A prediction tool for drug monitoring of adalimumab in rheumatoid arthritis.(2013)
- 강직성 척추염 환자에서 Adalimumab 치료 후 관찰된 천장관절염의 회복 1예 Running title: 강직성 척추염에서 Adalimumab 치료와 천장관절염의 회복(2012)
- → Summary of Research: Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial(2023)